[HTML][HTML] Patient reported outcomes in chronic inflammatory diseases: current state, limitations and perspectives

F Tran, JH Schirmer, I Ratjen, W Lieb… - Frontiers in …, 2021 - frontiersin.org
Chronic inflammatory diseases (CID) are emerging disorders which do not only affect
specific organs with respective clinical symptoms but can also affect various aspects of life …

Improved clinical staging system for localized pancreatic cancer using the ABC factors: A TAPS consortium study

EN Dekker, JL van Dam, QP Janssen… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE Previous studies suggest that besides anatomy (A: resectable, borderline
resectable [BR], or locally advanced [LA]) also biologic (B: carbohydrate antigen 19-9 [CA 19 …

The relationships between antihypertensive medications and the overall survival of patients with pancreatic cancer: a systematic review and meta-analysis

W Jiang, R He, Y Lu, W Zhou - Expert Review of Gastroenterology …, 2022 - Taylor & Francis
Background Antihypertensive medications may have some impacts on cancer. The influence
of antihypertensive medications, including angiotensin converting enzyme inhibitors …

Circulating protein biomarkers for use in pancreatic ductal adenocarcinoma identification

SC Lindgaard, Z Sztupinszki, E Maag, IM Chen… - Clinical Cancer …, 2021 - AACR
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid tumors.
Most patients are diagnosed at an advanced stage where curative surgery is not an option …

[HTML][HTML] Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection

WF Qu, PY Zhou, WR Liu, MX Tian, L Jin… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Comorbidity among cancer patients is prevalent and influential to prognosis
after operation. Limited data are available on comorbidity evaluations in patients with …

Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving …

E Jespersen, SB Winther, LR Minet, S Möller… - Journal of Geriatric …, 2021 - Elsevier
Objectives A growing number of older patients with cancer require well-founded clinical
decision-making. Frailty screening is suggested as a service to improve outcomes in …

[HTML][HTML] Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer

LS Rasmussen, MK Yilmaz, UG Falkmer… - European Journal of …, 2021 - Elsevier
Background Vitamin D deficiency and inflammation are associated with increased mortality.
We investigated the relationship between pre-treatment serum vitamin D levels …

Dilatation of the main pancreatic duct of unknown origin: causes and risk factors of pre-malignancy or malignancy

A Martin, J Cros, MP Vullierme, S Dokmak… - Surgical …, 2023 - Springer
Introduction A dilatation of the main pancreatic duct (MPD) is mainly due to obstructive
causes (pancreatic tumor, chronic pancreatitis) or intraductal papillary mucinous neoplasm …

[HTML][HTML] A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable …

LS Rasmussen, SB Winther, IM Chen, B Weber… - BMC cancer, 2023 - Springer
Background According to current evidence, the best treatment for fit patients with non-
resectable pancreatic cancer (PC) is combination chemotherapy, whereas frail patients are …

查尔森共病指数对慢加急性肝衰竭患者预后的评估价值.

王富春, 张万洁, 李子怡, 毛永武… - Journal of Clinical …, 2023 - search.ebscohost.com
目的评估查尔森共病指数(CCI) 对慢加急性肝衰竭(ACLF) 患者短期和长期死亡风险的预测价值.
方法纳入2016 年12 月1 日—2021 年12 月1 日就诊于兰州大学第一医院的ACLF 患者317 例 …